Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 3, 1997, Pages 410-417

  Rustenbeck, Ingo ^a   Herrmann, Cornelia ^a   Katzka, Peter ^a   Hasselblatt, Arnold ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

3H clonidine binding; Guanidinium compounds; Imidazoline binding sites; Imidazoline compounds; K(ATP) channels; Pancreatic B cells

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALINIDINE; ALPHA ADRENERGIC RECEPTOR; AMILORIDE; ANTAZOLINE; CLONIDINE; DIAZOXIDE; GUANABENZ; GUANETHIDINE; GUANIDINE DERIVATIVE; IDAZOXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE I2 RECEPTOR; PHENTOLAMINE; POTASSIUM CHANNEL; RADIOLIGAND; RILMENIDINE; SULFONYLUREA; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; BINDING SITE; CELL LINE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; MEMBRANE BINDING; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; RECEPTOR AFFINITY;

ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING, COMPETITIVE; CELL LINE; CELL MEMBRANE; CLONIDINE; DRUG INTERACTIONS; GUANIDINE; IMIDAZOLES; INSULIN; ISLETS OF LANGERHANS; MICE; PATCH-CLAMP TECHNIQUES; PHENTOLAMINE; POTASSIUM CHANNEL BLOCKERS; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, DRUG;

EID: 0030921569     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005070     Document Type: Article

References (54)

1. Ahrén B, Lundquist I (1985) Effects of α-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse. Acta Physiol Scand 125: 211-217
2. Atlas D (1991) Clonidine-displacing substance (CDS) and its putative imidazoline receptor. Biochem Pharmacol 41: 1541-1549
3. Berdeu D, Gross R, Puech R, Loubatières-Mariani M, Bertrand G (1995) Evidence for two different imidazoline binding sites on pancreatic B-cells and vascular bed. Eur J Pharmacol 275: 91-98
4. 2-adrenoceptor antagonists on glucose-induced hyperinsulinaemia in rats. Br J Pharmacol 89: 671P
5. Chan SLF, Morgan NG (1990) Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Br J Pharmacol 176: 97-101
6. ATP channels in insulin-secreting cells. Eur J Pharmacol 204: 41-48
7. 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site. Eur J Pharmacol 230: 375-378
8. 2 sites. Br J Pharmacol 112: 1065-1070
9. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzyme reaction. Biochem Pharmacol 22: 3099-3108
10. DeBlasi A, O'Reilly K, Motulsky HJ (1989) Calculating receptor number from binding experiments using same compounds as radioligand and competitor. Trends Pharmacol Sci 10: 227-229
11. Demolombe S, Escande D (1996) ATP-binding cassette proteins as targets for drug discovery. Trends Pharmacol Sci 17: 273-275
12. Dunne MJ (1991) Block of ATP-regulated potassium channels by phentolamine and other α-adrenoceptor antagonists. Br J Pharmacol 103: 1847-1850
13. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pflügers Arch 391: 85-100
14. Herrmann C, Ratzka P, Rustenbeck I, Hasselblatt A (1996) Binding sites of imidazoline- and guanidinium-compounds and functional relevance. Diabetologia 39: A121
15. Ibbotson T, Edwards G, Noack T, Weston AH (1993) Effects of P1060 and aprikalim on whole-cell currents in rat portal vein: inhibition by glibenclamide and phentolamine. Br J Pharmacol 108: 991-998
16. ATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166-1170
17. + channels in pancreatic β-cells. Br J Pharmacol 107: 8-14
18. 2-adrenoceptor antagonist. Eur J Pharmacol 254: 27-33
19. +-channels in pancreatic B-cells. Eur J Pharmacol 264: 81-84
20. Kakei M, Nakazaki M, Kamisaki T, Nagayama I, Fukamachi Y, Tanaka H (1993) Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic β-cells. Br J Pharmacol 109: 1226-1231
21. Kobinger W, Lillie C, Pichler L (1979) N-allyl-derivative of clonidine, a substance with a specific bradycardic action at a cardiac site. Naunyn-Schmiedeberg's Arch Pharmacol 306: 255-262
22. 2-adrenoceptors and of non-adrenergic imidazoline binding sites in pancreatic islets from young adult hamsters. Int J Biochem 25: 1077-1083
23. ATP channels in guinea pig ventricular myocytes. Eur J Pharmacol 285: 309-312
24. Lernmark A (1974) The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 10: 431-438
25. 3H]idazoxan label different populations of imidazoline sites on rat kidney. Eur J Pharmacol 232: 79-87
26. Michel MC, Ernsberger P (1992) Keeping an eye on the I site: imidazoline preferring-receptors. Trends Pharmacol Sci 13: 369-370
27. 1-imidazoline sites in bovine adrenal medullary membranes. Naunyn-Schmiedeberg's Arch Pharmacol 348: 70-76
28. 2-imidazoline sites. Naunyn-Schmiedeberg's Arch Pharmacol 350: 252-257
29. 2 binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 354: 245-252
30. 86Rb efflux and glibenclamide binding. Pflügers Arch 415: 47-55
31. 2 receptors. Eur J Pharmacol 262: 41-48
32. Olmos G, Ribera J, García-Sevilla JA (1996) Imidazoli(di)ne compounds interact with the phencyclidine site of NMDA receptors in the rat brain. Eur J Pharmacol 310: 273-276
33. 2-Adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with non insulin-dependent diabetes. J Clin Endocrinol Metab 67: 1054-1059
34. Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, Zünkler B, Lenzen S (1989) Control of insulin secretion by sulfonylureas, meglitinide, and diazoxide in relation to their binding to the sulfonylurea receptor. Biochem Pharmacol 38: 1217-1229
35. Panten U, Schwanstecher M, Schwanstecher C (1996) Sulfonylurea receptors and mechanism of sulfonylurea action. Exp Clin Endocrinol Diabetes 104: 1-9
36. Parini A, Moudanos CG, Pizzinat N, Lanier S (1996) The elusive family of imidazoline binding sites. Trends Pharmacol Sci 17: 13-16
37. Piletz JE, Stetten K (1993) Nonadrenergic imidazoline binding sites on human platelets. J Pharmacol Exp Ther 267: 1493-1502
38. +-channels in mouse pancrealic β-cells. Br J Pharmacol 101: 115-120
39. + channels in the kidney. Naunyn-Schmiedeberg's Arch Pharmacol 354: 213-225
40. Regunathan S, Reis DJ (1996) Imidazoline receptors and their endogenous ligands. Ann Rev Pharmacol Toxicol 36: 511-544
41. Remaury A, Paris H (1992) The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites. J Pharmacol Exp Ther 260: 417-426
42. Robertson RP, Porte D (1973) Adrenergic modulation of basal insulin secretion in man. Diabetes 22: 1-8
43. + channels in pancreatic B-cells. Clin Exp Endocrinol Diabetes 103 [Suppl 2]: 42-45
44. Rustenbeck I, Leupolt L, Dickel C, Herrmann C, Hasselblatt A (1997) The different characteristics of insulin secretion by imidazolines reflect their actions on potassium channels. Naunyn-Schmiedeberg's Arch Pharmacol 355: R82
45. + currents in Xenopus oocytes. Eur J Pharmacol 259: 223-231
46. Schulz A, Hasselblatt A (1988) Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release. Naunyn-Schmiedeberg's Arch Pharmacol 337: 637-643
47. Schulz A, Hasselblatt A (1989a) An insulin-releasing property of imidazoline derivatives is not limited to compounds that block α-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340: 712-714
48. Schulz A, Hasselblatt A (1989b) Dual action of clonidine on insulin release: Suppression, but stimulation when α-adrenoceptors are blocked. Naunyn-Schmiedeberg's Arch Pharmacol 340: 712-714
49. 2+-complex of ATP. J Pharmacol Exp Ther 262: 495-502
50. Smith M, Furman BL (1988) Augmentation of glucose-induced insulin secretion by pertussis vaccine, phentolamine and benextramine: involvement of mechanisms additional to prevention of the inhibitory actions of catecholamines in rats. Acta Endocrinol 118: 89-95
51. 3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible forms of the receptor. Pharmacol Toxicol 70: 208-219
52. Wilde AAM, Veldkamp MW, van Ginneken A, Opthof T (1994) Phentolamine blocks ATP sensitive potassium channels in cardiac ventricular cells. Cardiovasc Res 28: 847-850
53. ATP channels and interaction with the exocytotic machinery. Diabetes 45: 1610-1618
54. +-channels from pancreatic B-cells. FEBS Lett 239: 241-244